Stock Analysis on Net

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Enterprise Value (EV)

Microsoft Excel

Current Enterprise Value (EV)

Regeneron Pharmaceuticals Inc., current enterprise value calculation

Microsoft Excel
Current share price (P) $637.36
No. shares of common stock outstanding 109,324,682
US$ in thousands
Common equity (market value)1 69,679,179
Add: Preferred Stock, par value $.01 per share; issued and outstanding: none (per books)
Total equity 69,679,179
Add: Finance lease liabilities, current portion (per books)
Add: Long-term debt (per books) 1,984,400
Add: Finance lease liabilities, excluding current portion (per books) 720,000
Total equity and debt 72,383,579
Less: Cash and cash equivalents 2,488,200
Less: Marketable securities 6,524,300
Enterprise value (EV) 63,371,079

Based on: 10-K (reporting date: 2024-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= 637.36 × 109,324,682


Historical Enterprise Value (EV)

Regeneron Pharmaceuticals Inc., EV calculation

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Share price1, 2 $716.72 $936.33 $780.86 $622.36 $494.90
No. shares of common stock outstanding1 109,324,682 109,761,896 109,325,532 108,539,282 107,131,899
US$ in thousands
Common equity (market value)3 78,355,186 102,773,356 85,367,935 67,550,508 53,019,577
Add: Preferred Stock, par value $.01 per share; issued and outstanding: none (book value)
Total equity 78,355,186 102,773,356 85,367,935 67,550,508 53,019,577
Add: Finance lease liabilities, current portion (book value) 719,700
Add: Long-term debt (book value) 1,984,400 1,982,900 1,981,400 1,980,000 1,978,500
Add: Finance lease liabilities, excluding current portion (book value) 720,000 720,000 720,000 717,200
Total equity and debt 81,059,586 105,476,256 88,069,335 70,250,208 55,715,277
Less: Cash and cash equivalents 2,488,200 2,730,000 3,105,900 2,885,600 2,193,700
Less: Marketable securities 6,524,300 8,114,800 4,636,400 2,809,100 1,393,300
Enterprise value (EV) 72,047,086 94,631,456 80,327,035 64,555,508 52,128,277

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Regeneron Pharmaceuticals Inc. Annual Report.

3 2024 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= 716.72 × 109,324,682

Item Description The company
EV Enterprise value is total company value (the market value of common equity, debt, and preferred equity) minus the value of cash and short-term investments. Regeneron Pharmaceuticals Inc. EV increased from 2022 to 2023 but then decreased significantly from 2023 to 2024.